EE+ POEM Archive
Empagliflozin slows progression of renal disease in very high-risk patients with T2DM
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Empagliflozin Slows Progression of Renal Disease in Very High-risk Patients With T2DM." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314086/all/Empagliflozin_slows_progression_of_renal_disease_in_very_high_risk_patients_with_T2DM.
Empagliflozin slows progression of renal disease in very high-risk patients with T2DM. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314086/all/Empagliflozin_slows_progression_of_renal_disease_in_very_high_risk_patients_with_T2DM. Accessed September 15, 2024.
Empagliflozin slows progression of renal disease in very high-risk patients with T2DM. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314086/all/Empagliflozin_slows_progression_of_renal_disease_in_very_high_risk_patients_with_T2DM
Empagliflozin Slows Progression of Renal Disease in Very High-risk Patients With T2DM [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 September 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314086/all/Empagliflozin_slows_progression_of_renal_disease_in_very_high_risk_patients_with_T2DM.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Empagliflozin slows progression of renal disease in very high-risk patients with T2DM
ID - 1314086
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314086/all/Empagliflozin_slows_progression_of_renal_disease_in_very_high_risk_patients_with_T2DM
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
